...
search icon
mnkd-img

MannKind Corp Share Price

MNKD
NMQ
$5.53
+$0.09
(1.65%)
1D
Industry: Biotechnology Sector: Health Care

MannKind Corp Analyst Forecast

MannKind Corp Share Price Chart

MannKind Corp Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.67B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
50.7
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.89M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.38 L
$6.51 H
$5.53

About MannKind Corp, Common Stock

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut. more

Industry: BiotechnologySector: Health Care

MannKind Corp Stock Returns

Time FrameMNKDSectorS&P500
1-Week Return-1.78%1.07%0.74%
1-Month Return0.73%1.46%1.28%
3-Month Return10.6%3.51%3.6%
6-Month Return39.65%15.29%7.31%
1-Year Return0.36%7.7%11.97%
3-Year Return4.93%21.02%72.07%
5-Year Return-9.93%37.81%76.01%
10-Year Return12.86%139.15%258.47%

MannKind Corp Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue65.14M75.44M99.77M198.96M285.50M[{"date":"2020-12-31","value":22.82,"profit":true},{"date":"2021-12-31","value":26.42,"profit":true},{"date":"2022-12-31","value":34.95,"profit":true},{"date":"2023-12-31","value":69.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue24.64M38.86M57.50M62.77M76.60M[{"date":"2020-12-31","value":32.17,"profit":true},{"date":"2021-12-31","value":50.73,"profit":true},{"date":"2022-12-31","value":75.06,"profit":true},{"date":"2023-12-31","value":81.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit40.50M36.59M42.27M136.19M208.90M[{"date":"2020-12-31","value":19.39,"profit":true},{"date":"2021-12-31","value":17.51,"profit":true},{"date":"2022-12-31","value":20.24,"profit":true},{"date":"2023-12-31","value":65.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin62.17%48.49%42.37%68.45%73.17%[{"date":"2020-12-31","value":84.97,"profit":true},{"date":"2021-12-31","value":66.28,"profit":true},{"date":"2022-12-31","value":57.91,"profit":true},{"date":"2023-12-31","value":93.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses88.42M83.61M106.38M127.51M136.31M[{"date":"2020-12-31","value":64.86,"profit":true},{"date":"2021-12-31","value":61.33,"profit":true},{"date":"2022-12-31","value":78.04,"profit":true},{"date":"2023-12-31","value":93.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(47.91M)(47.02M)(64.11M)8.68M72.59M[{"date":"2020-12-31","value":-66.01,"profit":false},{"date":"2021-12-31","value":-64.78,"profit":false},{"date":"2022-12-31","value":-88.32,"profit":false},{"date":"2023-12-31","value":11.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(18.85M)(50.37M)(45.55M)(38.76M)(67.44M)[{"date":"2020-12-31","value":-1884900000,"profit":false},{"date":"2021-12-31","value":-5036900000,"profit":false},{"date":"2022-12-31","value":-4554600000,"profit":false},{"date":"2023-12-31","value":-3876200000,"profit":false},{"date":"2024-12-31","value":-6743500000,"profit":false}]
Pre-Tax Income(57.46M)(80.93M)(87.40M)(10.38M)30.52M[{"date":"2020-12-31","value":-188.28,"profit":false},{"date":"2021-12-31","value":-265.17,"profit":false},{"date":"2022-12-31","value":-286.39,"profit":false},{"date":"2023-12-31","value":-34,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(218.00K)10.87M24.77M1.56M2.93M[{"date":"2020-12-31","value":-0.88,"profit":false},{"date":"2021-12-31","value":43.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.3,"profit":true},{"date":"2024-12-31","value":11.83,"profit":true}]
Income After Taxes(57.24M)(91.79M)(112.17M)(11.94M)27.59M[{"date":"2020-12-31","value":-207.48,"profit":false},{"date":"2021-12-31","value":-332.72,"profit":false},{"date":"2022-12-31","value":-406.59,"profit":false},{"date":"2023-12-31","value":-43.27,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations(57.24M)(80.93M)(87.40M)(31.29M)27.59M[{"date":"2020-12-31","value":-207.48,"profit":false},{"date":"2021-12-31","value":-293.34,"profit":false},{"date":"2022-12-31","value":-316.8,"profit":false},{"date":"2023-12-31","value":-113.4,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(57.24M)(80.93M)(87.40M)(11.94M)27.59M[{"date":"2020-12-31","value":-207.48,"profit":false},{"date":"2021-12-31","value":-293.34,"profit":false},{"date":"2022-12-31","value":-316.8,"profit":false},{"date":"2023-12-31","value":-43.27,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.20)(0.23)(0.34)(0.05)0.11[{"date":"2020-12-31","value":-189.57,"profit":false},{"date":"2021-12-31","value":-218.01,"profit":false},{"date":"2022-12-31","value":-322.27,"profit":false},{"date":"2023-12-31","value":-43.32,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

MannKind Corp Ratios

MannKind Corp Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MNKD
Cash Ratio 2.38
Current Ratio 3.29
Quick Ratio 3.04

MannKind Corp Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MNKD
ROA (LTM) 9.95%
ROE (LTM) 0.00%

MannKind Corp Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MNKD
Debt Ratio Lower is generally better. Negative is bad. 1.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.09

MannKind Corp Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MNKD
Trailing PE 50.70
Forward PE 80.65
P/S (TTM) 5.32
P/B 0.00
Price/FCF 70
EV/R 5.09
EV/Ebitda 21.84
PEG NM

FAQs

What is MannKind Corp share price today?

MannKind Corp (MNKD) share price today is $5.53

Can Indians buy MannKind Corp shares?

Yes, Indians can buy shares of MannKind Corp (MNKD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MNKD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MannKind Corp be purchased?

Yes, you can purchase fractional shares of MannKind Corp (MNKD) via the Vested app. You can start investing in MannKind Corp (MNKD) with a minimum investment of $1.

How to invest in MannKind Corp shares from India?

You can invest in shares of MannKind Corp (MNKD) via Vested in three simple steps:

  • Click on Sign Up or Invest in MNKD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MannKind Corp shares
What is MannKind Corp 52-week high and low stock price?

The 52-week high price of MannKind Corp (MNKD) is $6.51. The 52-week low price of MannKind Corp (MNKD) is $3.38.

What is MannKind Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MannKind Corp (MNKD) is 50.7

What is MannKind Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MannKind Corp (MNKD) is 0.00

What is MannKind Corp dividend yield?

The dividend yield of MannKind Corp (MNKD) is 0.00%

What is the Market Cap of MannKind Corp?

The market capitalization of MannKind Corp (MNKD) is $1.67B

What is MannKind Corp's stock symbol?

The stock symbol (or ticker) of MannKind Corp is MNKD

How Can Investors Use MannKind Corp Share Price Data for Long-Term Investment Decisions?

Consider the share price of MannKind Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether MannKind Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from MannKind Corp shares for Indian investors?

When investing in MannKind Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the MannKind Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare MannKind Corp share price with other stocks in the same sector?

Rather than merely checking the share price of MannKind Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that MannKind Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top